Clinical research at Dognosis

Our clinical study program.

We run clinical studies across hospitals and community screening camps in India, working to detect cancer earlier, when it is most treatable. In partnership with clinicians and screening programs, we are evaluating a simple, non-invasive test in studies enrolling thousands of participants.

Recruiting now Multiple sites, Maharashtra & Karnataka CTRI-registered
Clinicians reviewing medical imaging
Registered clinical studies
Detecting cancer earlier
Clinical studies across India
This is clinical research. The test we are studying does not replace your normal check-ups, and a result is not a diagnosis. A doctor confirms any finding. Taking part is voluntary, and you can stop anytime.

The program

A rigorous, registered research program.

Our studies evaluate whether a non-invasive, breath-based test can help find cancer earlier, used alongside standard care. The program is registered and ethics-approved, runs across hospitals and community screening camps in Maharashtra and Karnataka, and is supported by a dedicated, regulated central laboratory. We work in partnership with clinicians and screening programs, and publish our findings openly.

Sponsor
Dognosis India Private Limited
Registered
CTRI/2025/07/091179
Oversight
Independent Ethics Committee
Sites
Hospitals & community camps
Central lab
CCSEA-approved, Bangalore

The studies

Two ways to take part.

Both studies test the same gentle breath test, sponsored by Dognosis and registered with the Clinical Trials Registry of India. Find the one that fits your situation. The study team confirms eligibility with you.

A clinician Recruiting

FirstAlert

Early detection & recurrence monitoring

FirstAlert tests how accurately BreathEasy detects many types of cancer, compared with standard screening and diagnosis. It runs across three groups of people over three years, to see whether a breath test can flag cancer earlier and more easily than today's methods.

Who it's for
Adults 18+ at higher risk, pre-biopsy, or post-cancer treatment
Visits
One, or several if monitoring recurrence
Where
Hospitals & screening camps, Maharashtra & Karnataka

Who can join

  • Higher-risk adults coming for routine cancer screening
  • People about to have a biopsy for a suspected cancer
  • People who finished cancer treatment and want to watch for any return
I'm interested in FirstAlert Prospective observational · 3 years · CTRI/2025/07/091179
A community screening clinician Recruiting

SANKET

Community screening study

SANKET is a community, camp-based study run with screening partners. It tests whether offering a breath pre-screen at camps helps find cancers at an earlier, more treatable stage than usual care. SANKET is part of the FirstAlert programme.

Who it's for
Adults 45+, higher risk, no cancer symptoms
Visits
One at the camp, plus 6 & 12-month check-ins
Where
Community screening camps with our partners

Who can join

  • You are 45 or older and have no cancer symptoms
  • You use tobacco, or a close relative has had cancer
  • You are attending a partnered screening camp
I'm interested in SANKET Camp-based screening study · 18 months · part of FirstAlert
Who should not take part right now, and what it costs

There is no cost to take part in either study, and the breath test is non-invasive.

You may not be able to join if any of these apply: an active, catching chest infection (such as tuberculosis, flu, or COVID-19); pregnancy, or having given birth in the last three months; a chest or airway procedure in the last two weeks; an active stomach ulcer or H. pylori infection, or an inflammatory bowel flare; another cancer or cancer treatment in the last five years; or a serious condition that makes it hard to give informed consent. The study team will check this with you.

How the test works

From your breath to a clear result.

Our bodies release tiny scent molecules in breath. Cancer can change that scent. We pair the remarkable nose of trained dogs with technology to read the signal.

01

You give a breath sample

Breathe normally into a soft, single-use mask for about ten minutes. That is the whole test.

02

Canine olfaction reads it

At our lab, trained detection dogs with a gentle wearable sensor smell your sealed sample. You never meet the dogs.

03

You get a clear result

Our software turns their response into a simple result: a signal detected, or not. A signal means look closer, not a diagnosis.

Explore the science & technology

After your result

What happens once we have your result.

Your sample gives a clear result: a signal detected, or not. Here is where each one leads. A signal means we look closer together, not that you have cancer.

Your breath resultA calibrated risk score: signal detected, or not detected
Not detected

Carry on as usual

Most people get this result. Keep up your normal health check-ups. No extra tests are needed unless your doctor advises otherwise. If you are in a follow-up group, we will still check in at your scheduled visits.

Signal detected

We help you look closer

1We confirm itWe repeat the breath test under careful conditions to be sure the signal is real.
2We reach outOur research team contacts you, and can arrange a repeat sample at home if that is easier for you.
3You see a doctorYou are referred for a clinical check and the right tests, such as imaging or a biopsy, to find out what is going on.
4A clear answerThe doctor confirms cancer or rules it out. Either way, we stay in touch and keep supporting you.

A signal is not a diagnosis. Many signals turn out not to be cancer. The aim of looking closer is simple: to find out early, either way, when there are the most options.

For hospitals & screening partners

Bring breath-based screening to your patients.

We partner with hospitals, oncology centres, and community screening programmes to add BreathEasy as a non-invasive pre-screening layer. We bring the science and the logistics; you reach more people, earlier.

Evidence-backedA test published in the Journal of Clinical Oncology, with over 90% sensitivity including early-stage disease.
Regulatory groundwork doneCTRI-registered, ethics-approved, and tested at our CCSEA-approved central laboratory.
Turnkey logisticsWe provide collection kits, cold-chain transport, and central testing. Minimal burden on your staff and space.
Fits your screeningAdds a breath pre-screen to your existing oral, breast, and cervical camps, and feeds positives into your diagnostic pathway.
A clinician

Let's build a programme together.

Co-authorship and shared research output, with full data transparency.

Talk to our partnerships team

Your team & your rights

Run by clinicians, with your rights first.

Experienced doctors and scientists lead the program, with independent ethics oversight. (Sponsor, registration, and lab details are in The program above.)

Dr. Sanjeev Kulgod
Chief Investigator & Medical Advisor
Dr. Shashikant Kulgod
Senior Medical Advisor
Dr. Sree Subha Ramaswamy
Lead R&D Scientist
Sahana Shanbhag
Clinical Lead
Akash Kulgod
Co-founder, Dognosis
Itamar Bitan
Co-founder, Dognosis

Your rights come first.

Taking part is completely voluntary. You can stop at any time, for any reason, without giving an explanation, and it will never affect your medical care. Your information is kept confidential and de-identified before analysis.

Questions

Frequently asked

Does it cost anything?

No. There is no cost to take the breath test as part of either study. If you need follow-up care, the team will guide you on your options.

Will the test tell me if I have cancer?

No. BreathEasy looks for a possible signal; it does not diagnose. If a signal is found, your doctor arranges proper tests. Dogs help detect; doctors diagnose.

Is it safe, and will the dogs come near me?

The test is very safe and non-invasive. You only breathe into a mask. The detection dogs never meet you; they smell your sealed sample later at our laboratory.

What if I change my mind after joining?

You can leave at any time, for any reason, without giving an explanation. It will not affect your medical care or rights. Just tell any team member.

Can my family or caregiver be involved?

Yes. You are welcome to bring a family member or caregiver to your visit and to any conversation with the team. Their support is valued.

We are a hospital. How do we partner with Dognosis?

We would love to talk. See For partners above, then email [email protected]. We handle the science, kits, and central testing, and work around your existing screening workflow.

Ready to take the next step?

Talk to us.

Whether you want to take part, are helping a loved one, or want to bring BreathEasy to your patients, we are here. There is no obligation, and every conversation is confidential.

Participants & caregivers

Join a study

Ask about eligibility for FirstAlert or SANKET, or just get your questions answered.

Email the study team
Hospitals & partners

Partner with us

Add breath-based screening to your programme, with our science and logistics behind you.

Talk to partnerships
Lab
Nelamangala, Bangalore
Tip
Discuss it with your doctor
FirstAlert (CTRI/2025/07/091179) and its SANKET sub-study are sponsored by Dognosis India Private Limited. BreathEasy is an investigational test and is not approved as a diagnostic. This page is for education and is not medical advice. Always consult a qualified doctor about your health.

Join the waitlist

Be first to know

We'll reach out the moment BreathEasy comes to your city.

Early access + 20% off at launch

No cost to join, no commitment.

Join the waitlist

50+ people already on the waitlist